Company intelligence / Profile preview

Sophion Bioscience

Ballerup/Copenhagen area, Denmark

Ownership: Private
Employees: ~88
Development stage: Commercial

Overview

Sophion Bioscience develops and manufactures automated patch clamp systems and cell line solutions that enable high-throughput functional characterization of ion channels. Their platforms are widely adopted by pharmaceutical and biotech companies for drug discovery, particularly in the field of electrophysiology.

Therapeutic areas: Other
Modalities: Device (Automated patch clamp platforms)Cell line solutions (for ion channel research)
Industry: Drug Discovery Services

Partnerships

Collaborates with pharmaceutical and biotech companies globally as customers; no major co-development partnerships disclosed.

Beyond the preview

Go deeper on Sophion Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sophion Bioscience.

Explore the full profile